CJC-1295 + Ipamorelin 10mg

CJC-1295 + Ipamorelin 10mg

$65.00
Skip to product information
CJC-1295 + Ipamorelin 10mg

CJC-1295 + Ipamorelin 10mg

$65.00

CJC-1295 + Ipamorelin 10mg – Growth Hormone Releasing Peptide Blend | ≥99% Purity

For laboratory research use only. Not for diagnostic, therapeutic, or human consumption.

CJC-1295 + Ipamorelin 10mg is a dual-peptide research blend formulated to stimulate endogenous growth hormone (GH) secretion through complementary mechanisms. This combination pairs a long-acting growth hormone-releasing hormone (GHRH) analog (CJC-1295) with a selective growth hormone secretagogue receptor (GHS-R) agonist (Ipamorelin), creating a synergistic approach to GH pulse amplification in laboratory models.

By targeting both GHRH receptors and ghrelin receptors, this peptide stack is widely studied in metabolic, body composition, recovery, and endocrine signaling research.


Mechanism of Action

The CJC-1295 + Ipamorelin blend works by stimulating natural growth hormone release through two distinct but complementary pathways:

CJC-1295 (GHRH Analog)

  • Activates GHRH receptors in the anterior pituitary

  • Prolongs GH pulse duration

  • Supports sustained IGF-1 elevation

  • Enhances physiologic GH signaling patterns

CJC-1295 is engineered for increased stability and extended half-life compared to native GHRH.

Ipamorelin (Ghrelin Receptor Agonist)

  • Selectively stimulates the growth hormone secretagogue receptor (GHS-R)

  • Triggers pulsatile GH release

  • Minimal impact on cortisol or prolactin in research models

  • Mimics ghrelin-mediated GH signaling

When combined, these peptides amplify growth hormone output more effectively than either compound alone, making this blend valuable for advanced endocrine and metabolic research.


Research Significance

Dual-pathway GH stimulation allows researchers to evaluate:

  • Enhanced pulsatile growth hormone dynamics

  • IGF-1 mediated tissue signaling

  • Lean mass preservation models

  • Recovery and regenerative signaling pathways

  • Lipid metabolism and fat distribution research

  • Sleep-related GH secretion studies

Unlike exogenous HGH administration, CJC-1295 + Ipamorelin supports natural endocrine feedback loops and physiologic hormone rhythms in laboratory settings.


Key Research Applications

  • Endogenous growth hormone stimulation studies

  • IGF-1 pathway research

  • Lean muscle mass and body composition models

  • Fat metabolism and lipid signaling investigations

  • Recovery and tissue regeneration research

  • Age-related GH decline studies

This peptide combination is commonly utilized in experimental models exploring anabolic signaling and metabolic optimization.


Product Specifications

  • Quantity: 10mg total blend per vial

  • Form: Lyophilized powder

  • Purity: ≥99%

  • Peptide Class: GHRH analog + GHS-R agonist combination

  • Composition: CJC-1295 + Ipamorelin blend


Storage & Handling

  • Store lyophilized peptide in a cool, dry place protected from light.

  • Reconstitute with bacteriostatic water prior to research use.

  • After reconstitution, refrigerate and use within the recommended research timeframe.


Sold per vial. Requires bacteriostatic water for reconstitution.
For laboratory research use only. Not for diagnostic, therapeutic, or human consumption.

You may also like